On March 6, 2018 Exelixis, Inc. (NASDAQ: EXEL) reported that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide an overview of the company at the following investor conferences in March (Press release, Exelixis, MAR 6, 2018, View Source;p=RssLanding&cat=news&id=2336592 [SID1234524445]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 38th Annual Health Care Conference: Exelixis is scheduled to present at 12:00 PM EDT / 9:00 AM PDT on Monday, March 12, 2018 in Boston.
Barclays Capital Global Healthcare Conference: Exelixis is scheduled to present at 11:15 AM EDT / 8:15 AM PDT on Tuesday, March 13, 2018 in Miami.
Oppenheimer 28th Annual Healthcare Conference: Exelixis is scheduled to present at 9:45 AM EDT / 6:45 AM PDT on Tuesday, March 20, 2018 in New York.
Needham Healthcare Conference: Exelixis is scheduled to present at 11:00 AM EDT / 8:00 AM PDT on Tuesday, March 27, 2018 in New York.
To access the webcast links, log onto www.exelixis.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading. Please connect to the company’s website at least 15 minutes prior to each presentation to ensure adequate time for any software download that may be required to listen to the webcasts. Replays will also be available at the same location for 14 days.